Delivery Order SPE2DB20D3103-SPE2DB23FP4T0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,338.30, is for the delivery of PADCEV 30 MG VIALS and has a completion date of December 26, 2023. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PADCEV 30 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,543.80 and a period of performance through March 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $25,863.30, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award, with a ceiling value of $14,602.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was not designated under any set-aside program. Amerisourcebergen is the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. doing business as Amerisourcebergen, for the provision of $24,999.30 worth of PADCEV 30 MG Vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG VIALS. The contract has a potential value of $24,999.30 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which supports military treatment programs and facilities with pharmaceuticals and medical supplies. This delivery order is issued under...
- This federal contract award, valued at $27,719.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, with an ultimate completion date of April 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is a $9,999.72 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award, issued by the Defense Logistics Agency (DLA), is for the supply of PADCEV 30 MG VIALS pharmaceutical products with a completion date of February 9, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has an extensive history of providing pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $29,205.96 for the pharmaceutical product PADCEV 30 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP4T0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $116,823.84, is for the delivery of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $116.8k | 8/23/23 |